614 MCKINLEY PL N E, MINNEAPOLIS, MN
Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
Other Events
Releases Fourth Quarter Fiscal 2026 Results
Bio-Techne Corporation Enters Merger Agreement with Merck KGaA
Agrees to Acquire, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
Releases Third Quarter Fiscal 2026 Results
Announces Changes to its Leadership Team
Releases Second Quarter Fiscal 2026 Results
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
PREM14A
Specialized Disclosure Report